Compositions for delivery of insoluble agents
    3.
    发明授权
    Compositions for delivery of insoluble agents 有权
    用于递送不溶性物质的组合物

    公开(公告)号:US08877746B2

    公开(公告)日:2014-11-04

    申请号:US13391440

    申请日:2010-08-24

    CPC分类号: A61K47/22 A61K31/5517

    摘要: Compositions and methods of making the same for in vivo delivery of lixivaptan to a subject in need thereof are described. The composition includes a substantially water-insoluble pharmacologically active agent (e.g., lixivaptan) and a substantially water-insoluble matrix forming material (e.g., a Vitamin E semi-ester), wherein the pharmacologically active agent is dispersed in said matrix forming material, and wherein the composition delivers said substantially water-insoluble pharmacologically active agent upon exposure to physiological medium.

    摘要翻译: 描述了将其用于体内递送泻药至有此需要的受试者的组合物和方法。 该组合物包括基本上不溶于水的药理学活性剂(例如,酏剂)和基本上不溶于水的基质形成材料(例如维生素E半酯),其中药理活性剂分散在所述基质形成材料中,和 其中所述组合物在暴露于生理介质时递送所述基本上不溶于水的药理活性剂。

    Compositions for Delivery of Insoluble Agents
    4.
    发明申请
    Compositions for Delivery of Insoluble Agents 有权
    组合物用于交付不溶物

    公开(公告)号:US20130079334A1

    公开(公告)日:2013-03-28

    申请号:US13391440

    申请日:2010-08-24

    IPC分类号: A61K47/22 A61K31/5517

    CPC分类号: A61K47/22 A61K31/5517

    摘要: Compositions and methods of making the same for in vivo delivery of lixivaptan to a subject in need thereof are described. The composition includes a substantially water-insoluble pharmacologically active agent (e.g., lixivaptan) and a substantially water-insoluble matrix forming material (e.g., a Vitamin E semi-ester), wherein the pharmacologically active agent is dispersed in said matrix forming material, and wherein the composition delivers said substantially water-insoluble pharmacologically active agent upon exposure to physiological medium.

    摘要翻译: 描述了将其用于体内递送泻药至有此需要的受试者的组合物和方法。 该组合物包括基本上不溶于水的药理学活性剂(例如,酏剂)和基本上不溶于水的基质形成材料(例如维生素E半酯),其中药理活性剂分散在所述基质形成材料中,和 其中所述组合物在暴露于生理介质时递送所述基本上不溶于水的药理活性剂。

    Stable Nanoparticle Formulations
    5.
    发明申请
    Stable Nanoparticle Formulations 审中-公开
    稳定的纳米粒子配方

    公开(公告)号:US20080038359A1

    公开(公告)日:2008-02-14

    申请号:US11874393

    申请日:2007-10-18

    申请人: Khawla ABU-IZZA

    发明人: Khawla ABU-IZZA

    IPC分类号: A61K9/14

    摘要: The invention relates to pharmaceutically stable nanoparticle formulations of poorly soluble drug substances, to the processes for the preparation of such formulations, and to methods of use thereof.

    摘要翻译: 本发明涉及药物稳定的难溶性药物物质的制剂,制备这些制剂的方法及其使用方法。